Cumberland Pharmaceuticals (CPIX) Gross Margin (2010 - 2026)
Cumberland Pharmaceuticals (CPIX) reported Gross Margin of 78.82% for Q1 2026, down 901.0% on a YoY basis from 9.84% in Q1 2025, and down 5.73% sequentially from 83.61% in Q4 2025.
Cumberland Pharmaceuticals (CPIX) Gross Margin (2010 - 2026) Analysis & Trends
Cumberland Pharmaceuticals (CPIX) has 17 years of Gross Margin data on file, last reported at 78.82% in Q1 2026.
- For the quarter ending Q1 2026, Gross Margin fell 901.0% year-over-year to 78.82%; the trailing twelve-month figure through Mar 2026 stood at 82.89% (down 144.0% YoY), and the FY2025 full-year result was 85.02%, up 242.0% from the prior year.
- Gross Margin eased to 78.82% in Q1 2026, from 83.61% in the prior quarter.
- In the past five years, Gross Margin ranged from a high of 88.08% in Q3 2025 to a low of 70.95% in Q4 2022.
- A 5-year average of 82.41% and a median of 82.49% in 2023 frame the typical range for Gross Margin.
- Across the five-year window, Gross Margin surged 1269 bps in 2023 and slumped 901 bps in 2026, its largest moves.
- Tracing CPIX's Gross Margin over 5 years: stood at 70.95% in 2022, then rose by 18 bps to 83.64% in 2023, then retreated by 3 bps to 81.06% in 2024, then gained by 3 bps to 83.61% in 2025, then slipped by 6 bps to 78.82% in 2026.
- Business Quant data shows CPIX's Gross Margin at 78.82% in Q1 2026, 83.61% in Q4 2025, and 88.08% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 49.52% |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 71.66% |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 62.93% |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 82.93% |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 32.97% |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 98.31% |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 57.26% |
| 10 | Cumberland Pharmaceuticals | 104.57 Mn | 93.23 Mn | 7.20 Mn | 78.82% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 78.82% |
| Dec 31, 2025 | 83.61% |
| Sep 30, 2025 | 88.08% |
| Jun 30, 2025 | 81.44% |
| Mar 31, 2025 | 87.83% |
| Dec 31, 2024 | 81.06% |
| Sep 30, 2024 | 85.44% |
| Jun 30, 2024 | 82.63% |
| Mar 31, 2024 | 81.46% |
| Dec 31, 2023 | 83.64% |
| Sep 30, 2023 | 82.49% |
| Jun 30, 2023 | 86.03% |
| Mar 31, 2023 | 86.45% |
| Dec 31, 2022 | 70.95% |
| Sep 30, 2022 | 80.51% |
| Jun 30, 2022 | 80.27% |
| Mar 31, 2022 | 80.21% |
| Dec 31, 2021 | 60.03% |
| Sep 30, 2021 | 83.55% |
| Jun 30, 2021 | 80.78% |